Recommendations from the EGAPP Working Group: does PCA3 testing for the diagnosis and management of prostate cancer improve patient health outcomes?
about
Using gene expression from urine sediment to diagnose prostate cancer: development of a new multiplex mRNA urine test and validation of current biomarkers.Epigenetically regulated microRNAs and their prospect in cancer diagnosis.Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer.Theoretical vs. empirical discriminability: the application of ROC methods to eyewitness identification.Detecting long non-coding RNA biomarkers in prostate cancer liquid biopsies: Hype or hope?
P2860
Recommendations from the EGAPP Working Group: does PCA3 testing for the diagnosis and management of prostate cancer improve patient health outcomes?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Recommendations from the EGAPP ...... prove patient health outcomes?
@en
type
label
Recommendations from the EGAPP ...... prove patient health outcomes?
@en
prefLabel
Recommendations from the EGAPP ...... prove patient health outcomes?
@en
P2860
P356
P1433
P1476
Recommendations from the EGAPP ...... prove patient health outcomes?
@en
P2093
Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group
P2860
P2888
P304
P356
10.1038/GIM.2013.141
P407
P577
2013-09-26T00:00:00Z
P5875
P6179
1035834712